This prospective study aims to evaluate clinical usefulness of low-voltage renal CT using low-concentration contrast agent and to compare with existing imaging techniques.

Inclusion Criteria:

• Subjects with no abnormalities in renal function (Serum creatinine < 1.4 mg/dl , GFR > 45mL/min/1.73 m2) in blood tests performed within one month
• Those who understand the contents of the research subject explanation and voluntarily sign the consent form

Exclusion Criteria:

• Body mass index > 30
• Subjects whose renal function abnormality was confirmed in a blood test (Serum creatinine > 1.4 mg/dl , GFR < 45mL/min/1.73 m2) conducted within one month
• Diabetic patients taking metformin
• Those with a history of urinary tract obstruction
• Those with a history of bladder, urinary tract, or kidney surgery that may affect the evaluation of the contrast agent in the renal parenchyma
• Those whose anatomical deformities have been identified in previous images that may interfere with image analysis
• Those who know or have been reported to have a history of contrast agent side effects in previous CT scans
• Those with a history of hypersensitivity or adverse reactions to iobrix (intravascular CT contrast) or iodine based agent
• Those with severe thyroid disease
• Pregnancy
• Those who are judged unsuitable for clinical trials by the researcher for reasons such as having other severe diseases or being judged to have a high risk of adverse reactions to intravascular contrast agents

Patients who need contrast enhanced CT scan for anatomical evaluation of kidney